Feedback

The Use of Calcium Phosphate-Based Starter Pellets for the Preparation of Sprinkle IR MUPS Formulation of Rosuvastatin Calcium

ORCID
0000-0001-9994-5626
Affiliation
Department of Pharmaceutical Technology, Faculty of Pharmacy, Medical University of Gdansk, al. Gen. J. Hallera 107, 80-416 Gdansk, Poland
Cal, Krzysztof;
ORCID
0000-0001-5894-7705
Affiliation
Department of Pharmaceutical Technology, Faculty of Pharmacy, Medical University of Gdansk, al. Gen. J. Hallera 107, 80-416 Gdansk, Poland
Mikolaszek, Barbara;
ORCID
0000-0002-3950-9010
Affiliation
Chemische Fabrik Budenheim KG, Rheinstrasse 27, 55257 Budenheim, Germany
Hess, Tobias;
Affiliation
Chemische Fabrik Budenheim KG, Rheinstrasse 27, 55257 Budenheim, Germany
Papaioannou, Markos;
Affiliation
Department of Analytical Chemistry, Institute of Chemical Sciences, Faculty of Chemistry, Maria Curie-Skłodowska University, M. Curie-Skłodowska Sq. 3, 20-031 Lublin, Poland
Lenik, Joanna;
Affiliation
Chair of Medical Biotechnology, Warsaw University of Technology, Noakowskiego 3, 00-664 Warsaw, Poland
Ciosek-Skibińska, Patrycja;
Affiliation
Harke Pharma GmbH, Xantener Straße 1, 45479 Mülheim an der Ruhr, Germany
Wall, Helene;
ORCID
0000-0003-1230-8128
Affiliation
Physiolution Polska sp. z o.o., Skarbowcow 81/7, 53-025 Wroclaw, Poland
Paszkowska, Jadwiga;
Affiliation
Physiolution Polska sp. z o.o., Skarbowcow 81/7, 53-025 Wroclaw, Poland
Romanova, Svitlana;
Affiliation
Physiolution Polska sp. z o.o., Skarbowcow 81/7, 53-025 Wroclaw, Poland
Garbacz, Grzegorz;
ORCID
0000-0003-3935-4263
Affiliation
Department of Pharmaceutical Technology, Faculty of Pharmacy, Medical University of Gdansk, al. Gen. J. Hallera 107, 80-416 Gdansk, Poland
Zakowiecki, Daniel

Sprinkle formulations represent an interesting concept of medicinal products aimed at the steadily growing population of patients suffering from swallowing difficulties (dysphagia). In the present work, immediate-release sprinkle MUPS (multiple-unit pellet system) containing rosuvastatin calcium as a model drug substance was successfully developed. The formulation was prepared by drug layering technique using novel calcium phosphate-based starting pellets (PharSQ ® Spheres CM) of three different particle sizes. The study showed that the developed multiparticulates were characterized by uniform distribution of coating layers thickness, as well as fast dissolution rate (more than 85% of rosuvastatin calcium dissolved within 30 min, as required by the relevant USP/NF monograph). Rosuvastatin calcium, like other statins, has a bitter, unpleasant taste. Investigations conducted with an electronic tongue suggested that the developed formulation achieved the desired taste-masking efficiency. The effect was found to be particle size-dependent, improving as the size of the multiparticulates increased.

Cite

Citation style:
Could not load citation form.

Access Statistic

Total:
Downloads:
Abtractviews:
Last 12 Month:
Downloads:
Abtractviews:

Rights

License Holder: © 2023 by the authors.

Use and reproduction: